In an early report, Shao et al.54 found that Plk1 inhibitor BI2536 treatment suppressed metformin-induced glycolysis and glutamine anaplerosis, both of which are survival responses of cells against mitochondrial poisons, implicating Plk1 inhibition to regulation of cancer metabolism. This evidence concerns the gene PLK1 and cancer.